Retinoid-related orphan receptor alpha (ROR alpha) (NR1F1) is a member of t
he nuclear receptor superfamily whose biological functions are largely unkn
own. Since staggerer mice, which carry a deletion in the ROR alpha gene, su
ffer from immune abnormalities, we generated an adenovirus encoding ROR alp
ha1 to investigate its potential role in control of the inflammatory respon
se. We demonstrated that ROR alpha is expressed in human primary smooth-mus
cle cells and that ectopic expression of ROR alpha1 inhibits TNF alpha -ind
uced IL-6, IL-8 and COX-2 expression in these cells. ROR alpha1 negatively
interferes with the NF-kappaB signalling pathway by reducing p65 translocat
ion as demonstrated by western blotting, immunostaining and electrophoretic
mobility shift assays. This action of ROR alpha1 on NF-kappaB is associate
d with the induction of I kappaB alpha, the major inhibitory protein of the
NF-kappaB signalling pathway, whose expression was found to be transcripti
onally upregulated by ROR alpha1 via a ROR response element in the I kappaB
alpha promoter. Taken together, these data identify ROR alpha1 as a potent
ial target in the treatment of chronic inflammatory diseases, including ath
erosclerosis and rheumatoid arthritis.